About | Free Trial

Last Update

2014-04-19T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Didier Reymond?

Dr. Didier Reymond

Executive Vice President, Clinical Development

Concordia Healthcare Corp

HQ Phone:

Concordia Healthcare Corp

2-1250 Waverley Street

Winnipeg, Manitoba R3T 6C6

Canada

Company Description

Concordia is a diverse, international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs. The Company has a strong international footprint with sales in more than 100 countries, and has a diversified portfolio of more than 2 ... more

Find other employees at this company (33)

Background Information

Employment History

Executive Vice President, Clinical Development
Thallion Pharmaceuticals Inc.

Executive Vice President, Clinical Development
Ecopia BioSciences Inc.

Education



Lausanne University , Medical School

MD

Web References (8 Total References)


Dr. Didier ...

www.canadianlifesciences.com [cached]

Dr. Didier Reymond Executive Vice-President, Clinical Development dreymond@thallion.com


Management : Thallion Pharmaceuticals

www.ecopiabio.com [cached]

Didier Reymond, MD

Executive Vice-President, Clinical Development
Dr. Reymond leads clinical development for all phases ofThallion's clinicalprograms. Before Thallion, he was a Senior Medical Advisorwith Novartis Canada, leading the medical and clinical activities for solid tumors. Prior to that, Dr. Reymond was Associate Director, Scientific Affairs, for the Merck Vaccine Division, Merck Frosst Canada. He was responsible for Regulatory Affairs and Medical Affairs for all vaccines in Canada. Dr. Reymond graduated from Lausanne University, Medical School,before working in Pediatric Surgery and completing his residency in Pediatrics at the University Hospitals of Lausanne and Bern.Board certified in Pediatrics, Dr. Reymond pursued a Fellowship in Pediatric Infectious Diseases at The Hospital for Sick Children, Toronto, where he conducted research activities on Verotoxin-producing Escherichia coli. Dr. Reymond completed his fellowship program at the Hôpital Sainte-Justine, in Montreal, conducting pediatric clinical research focusing on oral antibiotics.


Management : Thallion Pharmaceuticals

www.thallion.com [cached]

Didier Reymond, MD

Executive Vice-President, Clinical Development
Dr. Reymond leads clinical development for all phases ofThallion's clinicalprograms. Before Thallion, he was a Senior Medical Advisorwith Novartis Canada, leading the medical and clinical activities for solid tumors. Prior to that, Dr. Reymond was Associate Director, Scientific Affairs, for the Merck Vaccine Division, Merck Frosst Canada. He was responsible for Regulatory Affairs and Medical Affairs for all vaccines in Canada. Dr. Reymond graduated from Lausanne University, Medical School,before working in Pediatric Surgery and completing his residency in Pediatrics at the University Hospitals of Lausanne and Bern.Board certified in Pediatrics, Dr. Reymond pursued a Fellowship in Pediatric Infectious Diseases at The Hospital for Sick Children, Toronto, where he conducted research activities on Verotoxin-producing Escherichia coli. Dr. Reymond completed his fellowship program at the Hôpital Sainte-Justine, in Montreal, conducting pediatric clinical research focusing on oral antibiotics.


Didier Reymond VP ...

www.arena-international.com [cached]

Didier Reymond VP Clinical Development Thallion Pharmaceuticals


Didier Reymond, MD ...

www.canadianskin.ca [cached]

Didier Reymond, MD 514-228-3631 dreymond@thallion.com

Similar Profiles

Other People with this Name

Other people with the name Reymond

Nicholas Reymond
Chef's Garden Ltd

Nicholas Reymond
Chef's Garden Ltd

Laetitia Reymond
Kuoni Travel Ltd

Mike Reymond
Design Ad

Dominique Reymond
COLCOA limited

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory